ERRATUM article

Front. Mol. Biosci., 01 July 2022

Sec. Molecular Diagnostics and Therapeutics

Volume 9 - 2022 | https://doi.org/10.3389/fmolb.2022.968121

Erratum: A Drug Combination Rescues Frataxin-Dependent Neural and Cardiac Pathophysiology in FA Models

This article is an erratum on:

  1. A Drug Combination Rescues Frataxin-Dependent Neural and Cardiac Pathophysiology in FA Models

    1. Read original article
Frontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
A Drug Combination Rescues Frataxin-Dependent Neural and Cardiac Pathophysiology in FA Models

by Abeti, R., Jasoliya, M., Al-Mahdawi, S., Pook, M., Gonzalez-Robles, C., Hui, C. K., Cortopassi, G., and Giunti, P. (2022). Front. Mol. Biosci. 9:830650. doi: 10.3389/fmolb.2022.830650

Due to a production error, the Funding statement for this article was omitted:

“We would like to thank the funders that supported us, in particular FARA (Bronya J. Keats International Research Collaboration Award) and an NIH grant we received (4R33NS106719-03 Pharmacodynamics and in vivo efficacy of fumarate for mitochondrial disease in vivo). Besides, we would like to acknowledge the UCLH/UCL for which PG works and receives a proportion of funding from the Department of Health's NIHR Biomedical Research Centers funding scheme, and the support given by the CRN: North Thames, National Institute for Health Research.”

The publisher apologizes for this mistake. The original version of this article has been updated.

Keywords: friedreich’s ataxia (FA), frataxin (FXN), dimethyl fumarate (DMF), resveratrol (Resv), mitochondrial membrane potential (ΔΨm), reactive oxygen species (ROS)

Citation: (2022) Erratum: A Drug Combination Rescues Frataxin-Dependent Neural and Cardiac Pathophysiology in FA Models. Front. Mol. Biosci. 9:968121. doi: 10.3389/fmolb.2022.968121

Received: 13 June 2022; Accepted: 13 June 2022;
Published: 01 July 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Frontiers Production Office . This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.